Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats - PubMed (original) (raw)
Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats
Randy L Hunter et al. Neurosci Lett. 2008.
Abstract
We created an inflammation-induced Parkinson's disease model, where microglia activation leads to oxidative stress, mitochondrial dysfunction, and dopaminergic neurodegeneration in the substantia nigra. Pioglitazone, an agonist of peroxisome proliferator activated receptor-gamma (PPAR-gamma), can prevent these deficits and protect dopaminergic neurons. To continue exploring the effects of pioglitazone in this model we focused on the expression of PPAR-gamma, uncoupling protein 2 (UCP2), and mitoNEET. We report that intrastriatal lipopolysaccharide (LPS) increases striatal PPAR-gamma, UCP2, and mitoNEET expression, and pioglitazone attenuates these LPS-induced changes.
Figures
Figure 1
Western blot analysis shows a trend for LPS to increase PPAR-γ expression. In addition, LPS significantly increases both UCP2 and mitoNEET. Treatment with pioglitazone significantly attenuates the LPS-induced increase in PPAR-γ, UCP2, and mitoNEET (Figure 1A). Data are expressed as means +/−SEM, from n=3–5/group, ** or ## = p≤ 0.01, where ** represents Vehicle/Saline (V/S) vs. Vehicle/LPS (V/L) and ## represents Vehicle/LPS vs. Pioglitazone/LPS (P/L). Figure 1B shows representative blots for PPAR-γ, UCP2, mitoNEET, and beta-actin.
Similar articles
- Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.
Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing G. Hunter RL, et al. J Neurochem. 2007 Mar;100(5):1375-86. doi: 10.1111/j.1471-4159.2006.04327.x. Epub 2007 Jan 23. J Neurochem. 2007. PMID: 17254027 - Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt.
Xing B, Xin T, Hunter RL, Bing G. Xing B, et al. J Neuroinflammation. 2008 Jan 18;5:4. doi: 10.1186/1742-2094-5-4. J Neuroinflammation. 2008. PMID: 18205920 Free PMC article. - Activation of PPAR-γ by pioglitazone attenuates oxidative stress in aging rat cerebral arteries through upregulating UCP2.
Wang P, Li B, Cai G, Huang M, Jiang L, Pu J, Li L, Wu Q, Zuo L, Wang Q, Zhou P. Wang P, et al. J Cardiovasc Pharmacol. 2014 Dec;64(6):497-506. doi: 10.1097/FJC.0000000000000143. J Cardiovasc Pharmacol. 2014. PMID: 25490415 - Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
Matsuda J, Hosoda K, Itoh H, Son C, Doi K, Hanaoka I, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Odaka H, Nakao K. Matsuda J, et al. Diabetes. 1998 Nov;47(11):1809-14. doi: 10.2337/diabetes.47.11.1809. Diabetes. 1998. PMID: 9792555 - Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature.
Alhowail A, Alsikhan R, Alsaud M, Aldubayan M, Rabbani SI. Alhowail A, et al. Drug Des Devel Ther. 2022 Aug 31;16:2919-2931. doi: 10.2147/DDDT.S367229. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36068789 Free PMC article. Review.
Cited by
- Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanisms.
Griggs RB, Donahue RR, Morgenweck J, Grace PM, Sutton A, Watkins LR, Taylor BK. Griggs RB, et al. Pain. 2015 Mar;156(3):469-482. doi: 10.1097/01.j.pain.0000460333.79127.be. Pain. 2015. PMID: 25599238 Free PMC article. - Peroxisome proliferator-activated receptor-γ agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus.
San YZ, Liu Y, Zhang Y, Shi PP, Zhu YL. San YZ, et al. Mol Med Rep. 2015 Aug;12(2):1877-83. doi: 10.3892/mmr.2015.3641. Epub 2015 Apr 17. Mol Med Rep. 2015. PMID: 25891824 Free PMC article. - High Fat Diet Suppresses Peroxisome Proliferator-Activated Receptors and Reduces Dopaminergic Neurons in the Substantia Nigra.
Kao YC, Wei WY, Tsai KJ, Wang LC. Kao YC, et al. Int J Mol Sci. 2019 Dec 27;21(1):207. doi: 10.3390/ijms21010207. Int J Mol Sci. 2019. PMID: 31892244 Free PMC article. - Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
Blalock EM, Phelps JT, Pancani T, Searcy JL, Anderson KL, Gant JC, Popovic J, Avdiushko MG, Cohen DA, Chen KC, Porter NM, Thibault O. Blalock EM, et al. PLoS One. 2010 Apr 29;5(4):e10405. doi: 10.1371/journal.pone.0010405. PLoS One. 2010. PMID: 20454453 Free PMC article. - Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.
Parra I, Martínez I, Ramírez-García G, Tizabi Y, Mendieta L. Parra I, et al. Neurotox Res. 2020 Jan;37(1):1-11. doi: 10.1007/s12640-019-00104-z. Epub 2019 Sep 2. Neurotox Res. 2020. PMID: 31478124
References
- Andrews ZB, Rivera A, Elsworth JD, Roth RH, Agnati L, Gago B, Abizaid A, Schwartz M, Fuxe K, Horvath TL. Uncoupling protein-2 promotes nigrostriatal dopamine neuronal function. Eur J Neurosci. 2006;24:32–36. - PubMed
- Arimoto T, Bing G. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiol Dis. 2003;12:35–45. - PubMed
- Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, Couplan E, Alves-Guerra MC, Goubern M, Surwit R, Bouillaud F, Richard D, Collins S, Ricquier D. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet. 2000;26:435–439. - PubMed
- Bernardo A, Minghetti L. PPAR-gamma agonists as regulators of microglial activation and brain inflammation. Curr Pharm Des. 2006;12:93–109. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical